Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / News/  Cipla cuts prices of 3 cancer drugs by up to 64%
BackBack

Cipla cuts prices of 3 cancer drugs by up to 64%

Lung cancer drug Erlocip would cost `9,900 for 30 tablets, while breast cancer treatment Docetax would be priced at `1,650

A file photo of a Cipla research and development facility in Patalganga, Mumbai. (A file photo of a Cipla research and development facility in Patalganga, Mumbai.)Premium
A file photo of a Cipla research and development facility in Patalganga, Mumbai.
(A file photo of a Cipla research and development facility in Patalganga, Mumbai.)

Cipla Ltd cut prices of three cancer drugs between 50% and 64% with immediate effect, after it announced similar price cuts for three drugs early this year.

Lung cancer drug Erlocip would cost 9,900 for 30 tablets instead of 27,000 earlier, while breast cancer treatment Docetax would be priced 1,650 instead of 3,300, Cipla said in a statement on Thursday.

Cipla last month won a case against Roche Holding AG, which accused the Indian company of infringing patent on cancer drug Tarceva, which Cipla sells under the brand name Erlocip.

Capegard, another drug to treat metastatic colorectal and colon caner, would be priced 600 for 10 tablets instead of 1,200, it said.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 08 Nov 2012, 01:32 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie